Dec 8 (Reuters) - Disc Medicine Inc IRON.O:
DISC MEDICINE PRESENTS POSITIVE UPDATED RESULTS FROM PHASE 1B TRIAL IN PATIENTS WITH MYELOFIBROSIS (MF) AND ANEMIA IN AN ORAL PRESENTATION AT THE 66TH AMERICAN SOCIETY OF HEMATOLOGY $(ASH)$ ANNUAL MEETING
Source text: ID:nGNX59bt1l
Further company coverage: IRON.O
((Reuters.Briefs@thomsonreuters.com;))